Chi Huang
Plus aucun poste en cours
Historique de carrière de Chi Huang
Anciens postes connus de Chi Huang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Directeur/Membre du Conseil | - | - |
| GUANGDONG FAITH LONG CRYSTAL TECHNOLOGY CO.,LTD. | Directeur/Membre du Conseil | 01/11/2011 | - |
| Independent Dir/Board Member | 01/11/2011 | - |
Formation de Chi Huang
| Jiangxi University of Finance & Economics | Undergraduate Degree |
Statistiques
Internationale
| Chine | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Electronic Technology | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GUANGDONG FAITH LONG CRYSTAL TECHNOLOGY CO.,LTD. | Electronic Technology |
| Entreprise privées | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
